Soon we will get upgrade news, this will boost the price extra. I think they will upgrade the stock to $10,00 for the current year. The current shareprice is extreme undervalued. If they will get FDA approval than we could see share price upgrades which will be extreme higher. But I think that a big pharma will soon buy out Genprex even before the FDA decision. Either way, we will have big profits this year.. ...
Market Data 
Markets 
AI
